The accumulation of antibiotics in the aquatic environment is increasingly becoming a risk to the health of aquatic animal. The purpose of this study was to investigate the acute and chronic toxicity of florfenicol (FF) to zebrafish. A 56-day chronic toxicity test followed a 96-h acute toxicity test. The chronic toxicity test was divided into five FF concentration groups: 0 mg/L (C), 5 mg/L (T5), 10 mg/L (T10), 20 mg/L (T20) and 40 mg/L (T40). Each group had five replicates, with 20 Zebrafish per replicate. The acute toxicity test results showed that the 96 h-LC50 of FF was greater than 2000 mg/L, indicating low toxicity. The exposure concentrations of FF exceeding 20 mg/L can cause oxidative damage to the liver and gill tissues of fish, leading to the accumulation of oxidative products in the tissues and severe damage to antioxidant capacity. The reactive oxygen species (ROS) generated by severe oxidative stress activates the toll like receptors (TLR) pathway, inducing inflammation in the liver and gill tissues, stimulating the upregulation of inflammatory factor expression levels, and leading to immune system disorders. FF exposure at a concentration of 5 mg/L can lead to a significant decrease in the diversity and evenness of gut microbiota. The concentration of FF in water bodies above 37.52 mg/L poses a potential risk to aquatic products.
1. Erlotinib, a small-molecule epidermal growth factor receptor-tyrosine kinase (EGFR-TK) inhibitor, has been approved for the management of advanced non-small cell lung cancer. The aim of the present study was to investigate whether erlotinib exerts potent antitumour activities through the reactive oxygen species (ROS)-c-Jun N-terminal kinase (JNK) pathway in the human non-small cell lung cancer cell line A549. 2. The 3-(4,5-dimethyl-2 thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and Hoechst 33342 staining showed that erlotinib produced a decline in cell viability of A549 cells and induced cell apoptosis, coupled with quick accumulation of ROS. In addition, erlotinib increased the respiratory control ratio, NADPH oxidase catalytic subunit gp91(phox) expression and superoxide anion (O2(-)) generation, suggesting that erlotinib induced ROS production in A549 cells from both mitochondrial and NADPH oxidase sources. 3. Fluorescence microscopy with the JC-1 probe and western blot analysis indicated that erlotinib induced loss of mitochondrial membrane potential, the release of cytochrome c and apoptosis-inducing factor (AIF) and activation of JNK. 4. The results of the present study suggest that erlotinib has potent antitumour activity in A549 cells by activating ROS-dependent, JNK-driven cell apoptosis. These findings provide a novel insight into the mechanism of action of erlotinib in the treatment of human non-small cell lung cancer in addition to its effects in inhibiting EGFR-TK.
The fundamental mechanism behind oil/water separation materials is their surface wettability that allows either oil or water to pass through. The conventional materials for oil/water separation generally have extreme wettability, namely superhydrophilic for water separation and superhydrophobic for oil separation. Using easily accessible materials that are medium hydrophobic or even relatively hydrophilic for preparing highly efficient oil/water separators have rarely been reported. In this work, a new strategy by triggering phase transition of infused lubricant from liquid to solid state in porous structure is realized in fabricating slippery lubricant infused porous structure for oil/water separations. By infusing polyester fabric with coconut oil, after phase transition, excellent water repellency and oil permeability by an absorbing-permeating mechanism are achieved, despite the low water contact angle on the new material. Although the new phase transformable slippery lubricant infused porous structure, features much milder hydrophobicity than conventional oil/water separators, it can remove diverse types of oil from water with high efficiencies. The phase transformable slippery lubricant infused porous structure is able to maintain their water repellency after immersing in high concentration salt (10 wt% NaCl), acid (25 % HCl), alkaline (25 % NH3·H2O) solutions for 120 h, showing remarkably functional durability in harsh environment. The lubricant phase transition mechanism proposed in this study is universally applicable to porous substrates with various chemical compositions and pore structures, such as porous sponges or even daily life breads, for creating efficient oil/water separators, which can serve as a novel accessible design principle of phase transformable slippery lubricant infused porous structure for eco-friendly oil/water separators.
Abstract Improving the osteogenic activity of BMP-2 in vivo has significant clinical application value. In this research, we use a clinical gelatin sponge scaffold loaded with BMP-2 and dexamethasone (Dex) to evaluate the osteogenic activity of dual drugs via ectopic osteogenesis in vivo. We also investigate the mechanism of osteogenesis induced by BMP-2 and Dex with C2C12, a multipotent muscle-derived progenitor cell. The results show that the gelatin scaffold with Dex and BMP-2 can significantly accelerate osteogenesis in vivo. It is indicated that compared with the BMP-2 or Dex alone, 100 nM of Dex can dramatically enhance the BMP-2-induced alkaline phosphatase activity (ALP), ALP mRNA expression and mineralization. Further studies show that 100 nM of Dex can maintain the secondary structure of BMP-2 and facilitate recognition of BMP-2 with its receptors on the surface of C2C12 cells. We also find that in C2C12, Dex has no obvious effect on the BMP-2-induced Smad1/5/8 protein expression and the STAT3-dependent pathway, but Runx2-dependent pathway is involved in the Dex-stimulated osteoblast differentiation of BMP-2 both in vitro and in vivo. Based on these results, a potential mechanism model about the synergistic osteoinductive effect of Dex and BMP-2 in C2C12 cells via Runx2 activation is proposed. This may provide a theoretical basis for the pre-clinical application of Dex and BMP-2 for bone regeneration.
4-Chlorobenzoyl-coenzyme A (4-CBA-CoA) dehalogenase catalyzes the hydrolytic dehalogenation of 4-CBA-CoA by attack of Asp145 on the C(4) of the substrate benzoyl ring to form a Meisenheimer intermediate (EMc), followed by expulsion of chloride ion to form an arylated enzyme intermediate (EAr) and, finally, ester hydrolysis in EAr to form 4-hydroxybenzoyl-CoA (4-HBA-CoA). This study examines the contribution of the active site His90 to catalysis of this reaction pathway. The His90 residue was replaced with glutamine by site-directed mutagenesis. X-ray crystallographic analysis of H90Q dehalogenase complexed with 4-HBA-CoA revealed that the positions of the catalytic groups are unchanged from those observed in the structure of the 4-HBA-CoA−wild-type dehalogenase complex. The one exception is the Gln90 side chain, which is rotated away from the position of the His90 side chain. The vacated His90 site is occupied by two water molecules. Kinetic techniques were used to evaluate ligand binding and catalytic turnover rates in the wild-type and H90Q mutant dehalogenases. The rate constants for 4-CBA-CoA (both 7 μM-1 s-1) and 4-HBA-CoA (33 and 11 μM-1 s-1) binding to the two dehalogenases are similar in value. For wild-type dehalogenase, the rate constant for a single turnover is 2.3 s-1 while that for multiple turnovers is 0.7 s-1. For H90Q dehalogenase, these rate constants are 1.6 × 10-2 and 2 × 10-4 s-1. The rate constants for EMc formation in wild-type and mutant dehalogenase are ∼200 s-1 while the rate constants for EAr formation are 40 and 0.3 s-1, respectively. The rate constant for hydrolysis of EAr in wild-type dehalogenase is 20 s-1 and in the H90Q mutant, 0.13 s-1. The 133-fold reduction in the rate of EAr formation in the mutant may be the result of active site hydration, while the 154-fold reduction in the rate EAr hydrolysis may be the result of lost general base catalysis. Substitution of the His90 with Gln also introduces a rate-limiting step which follows catalysis, and may involve renewing the catalytic site through a slow conformational change.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)